GenScript Biotech to Hold Board Meeting to Approve Annual Results and Consider Dividend

Reuters03-04
<a href="https://laohu8.com/S/01548">GenScript</a> Biotech to Hold Board Meeting to Approve Annual Results and Consider Dividend

GenScript Biotech Corporation will hold a board meeting on Sunday, 15 March 2026 to consider and approve the group’s annual results for the year ended 31 December 2025, the publication of those results, and the payment of an annual dividend, if any.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260304-12039704), on March 04, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment